4.7 Article

The Association of Oral Bisphosphonate Use With Mortality Risk Following a Major Osteoporotic Fracture in the United Kingdom: Population -Based Cohort Study

Journal

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jamda.2019.11.003

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Rheumatology

Response to: 'Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study'' by Zheng

Shahab Abtahi, Johanna H. M. Driessen, Andrea M. Burden, Patrick C. Souverein, Joop P. van den Bergh, Tjeerd P. van Staa, Annelies Boonen, Frank de Vries

ANNALS OF THE RHEUMATIC DISEASES (2023)

Letter Rheumatology

Response to: 'Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study' by Gong and Zhang and Lin et al

Shahab Abtahi, Johanna H. M. Driessen, Andrea M. Burden, Patrick C. Souverein, Joop P. van den Bergh, Annelies Boonen

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Urology & Nephrology

His452Tyr 5-HT2A polymorphism and intravaginal ejaculation latency time in Dutch men with lifelong premature ejaculation

J. J. van Raaij, K. H. Hua, F. de Vries, Paddy K. C. Janssen

Summary: This study aimed to investigate the relationship between the His452Tyr polymorphism of the 5-HT2A receptor and the pathogenesis and intravaginal ejaculation latency time (IELT) differences in patients with lifelong premature ejaculation (LPE). The results showed no correlation between the polymorphism and IELT distribution in LPE patients.

INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2023)

Article Orthopedics

What Is the Diagnostic Performance of Conventional Radiographs and Clinical Reassessment Compared With HR-pQCT Scaphoid Fracture Diagnosis?

Anne M. Daniels, Josephine Kranendonk, Caroline E. Wyers, Heinrich M. J. Janzing, Sander Sassen, Bert van Rietbergen, Piet P. M. M. Geusens, Sjoerd Kaarsemaker, Pascal F. W. Hannemann, Martijn Poeze, Joop P. van den Bergh

Summary: This study evaluated the value of conventional radiographs and clinical reassessment in diagnosing clinically suspected scaphoid fractures. The results showed that both conventional radiographs and clinical reassessment had limited accuracy in diagnosing scaphoid fractures and cannot be considered as directive diagnostic methods.

CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2023)

Article Endocrinology & Metabolism

Site-Specific Fracture Incidence Rates Among Patients With Type 1 Diabetes, Type 2 Diabetes, or Without Diabetes in Denmark (1997-2017)

Annika Vestergaard Kvist, Mohamad I. Nasser, Peter Vestergaard, Morten Frost, Andrea M. Burden

Summary: A study in Denmark from 1997 to 2017 found that the incidence rates of fractures were higher in patients with type 1 and type 2 diabetes compared to those without diabetes, except for foot fractures. The incidence of hip fractures decreased by 35.2%, 47.0%, and 23.4% in patients with type 1 diabetes, type 2 diabetes, and without diabetes, respectively, over the last 5 years. However, vertebral fractures increased by 14.8%, 18.5%, and 38.9% in the same groups. After age adjustment, patients with type 1 diabetes still had a higher risk of fractures compared to those without diabetes, while patients with type 2 diabetes had a risk similar to those without diabetes.

DIABETES CARE (2023)

Article Critical Care Medicine

CT Scan-Derived Muscle, But Not Fat, Area Independently Predicts Mortality in COVID-19

Sophie I. J. van Bakel, Hester A. Gietema, Patricia M. Stassen, Harry R. Gosker, Debbie Gach, Joop P. van den Bergh, Frits H. M. van Osch, Annemie M. W. J. Schols, Rosanne J. H. C. G. Beijers

Summary: This study found that CT scan-derived low pectoralis muscle CSA is significantly associated with higher 30-day in-hospital mortality in patients with COVID-19 independently of the 4C Mortality Score.

CHEST (2023)

Article Public, Environmental & Occupational Health

Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study

Shahab Abtahi, Romin Pajouheshnia, Carlos E. Duran, Judit Riera-Arnau, Magdalena Gamba, Ema Alsina, Vjola Hoxhaj, Morten Andersen, Claudia Bartolini, Sarah Brogger Kristiansen, Jeremy Brown, Christine Erikstrup Hallgreen, Patricia Garcia-Poza, Helga Gardarsdottir, Rosa Gini, Anna Girardi, Emily Holthuis, Consuelo Huerta, Luisa Ibanez, Giorgio Limoncella, Mar Martin-Perez, Olga Paoletti, Giuseppe Roberto, Patrick Souverein, Karin M. A. Swart, Kevin Wing, Miriam Sturkenboom, Olaf Klungel

Summary: This study investigated the effectiveness of the 2018 EU risk minimisation measures (RMMs) for valproate in five European countries/regions. The results showed a small impact of these measures on valproate utilization, although there was a decline in some countries/regions. The substantial number of concurrent pregnancies during valproate exposure highlights the need for careful monitoring and potential additional measures in the future.

DRUG SAFETY (2023)

Article Rheumatology

Cancer risk in patients with rheumatoid arthritis treated with janus kinase inhibitors: a nationwide Danish register-based cohort study

Rasmus Westermann, Rene Lindholm Cordtz, Kirsten Duch, Lene Mellemkjaer, Merete Lund Hetland, Andrea Michelle Burden, Lene Dreyer

Summary: This study examined the risk of first primary cancer in patients with rheumatoid arthritis (RA) treated with janus kinase inhibitors (JAKi) compared to those treated with biologic disease-modifying antirheumatic drugs (bDMARDs) in a real-world setting. The results showed that JAKi treatment was not associated with a statistically significant increased risk of first primary cancer compared to bDMARDs treatment in RA patients.

RHEUMATOLOGY (2023)

Article Pharmacology & Pharmacy

An explorative analysis of pharmacovigilance data of oxytocin and its analogue carbetocin, with a focus on haemodynamic adverse effects

Dominik Stampfli, Rebecca Dommrich, Sharon Orbach-Zinger, Andrea M. Burden, Michael Heesen

Summary: This study analyzed the adverse drug events and haemodynamic profile of oxytocin and carbetocin using data from the World Health Organization's pharmacovigilance database. The results showed that carbetocin had a higher reporting of adverse hypertension, hypotension, and tachycardia compared to oxytocin. Therefore, clinicians should be cautious of their patients' susceptibility and the potential haemodynamic deterioration when using these drugs.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2023)

Article Pharmacology & Pharmacy

Comparison of Fracture Identification Using Different Definitions in Healthcare Administrative (Claims) Data

Natalia Konstantelos, Andrea M. Burden, Angela M. Cheung, Sandra Kim, Paul Grootendorst, Suzanne M. Cadarette

Summary: This study aimed to compare fracture rates estimated using different definitions and found that coding decisions have a significant impact on fracture outcome definitions. The study highlights the importance and impact of coding decisions on fracture outcome identification and emphasizes the need for further research to inform best practice in fracture outcome identification.

PHARMACY (2023)

Article Multidisciplinary Sciences

JAK-inhibitors and risk on serious viral infection, venous thromboembolism and cardiac events in patients with rheumatoid arthritis: A protocol for a prevalent new-user cohort study using the Danish nationwide DANBIO register

Maria Luisa Faquetti, Enriqueta Vallejo-Yague, Rene Cordtz, Lene Dreyer, Andrea M. Burden

Summary: Janus Kinase inhibitors (JAKis) are important synthetic drugs used to treat rheumatoid arthritis (RA) patients. However, there have been debates regarding the safety concerns associated with JAKi use, including increased risk for venous thromboembolism (VTE), serious viral infection, and major adverse cardiovascular events (MACE). This study aims to enrich the safety profile of JAKis using real-world data from the Danish DANBIO registry.

PLOS ONE (2023)

Article Pharmacology & Pharmacy

Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis

Carlos E. Duran, Judit Riera-Arnau, Shahab Abtahi, Romin Pajouheshnia, Vjola Hoxhaj, Magdalena Gamba, Ema Alsina, Mar Martin-Perez, Patricia Garcia-Poza, Ana Llorente-Garcia, Diana Gonzalez-Bermejo, Luisa Ibanez, Monica Sabate, Xavier Vidal, Elena Ballarin, Gabriel Sanfelix-Gimeno, Clara Rodriguez-Bernal, Salvador Peiro, Anibal Garcia-Sempere, Francisco Sanchez-Saez, Valentina Ientile, Ylenia Ingrasciotta, Claudio Guarneri, Matilde Tanaglia, Michele Tari, Ron Herings, Eline Houben, Karin Swart-Polinder, Emily Holthuis, Consuelo Huerta, Rosa Gini, Giuseppe Roberto, Claudia Bartolini, Olga Paoletti, Giorgio Limoncella, Anna Girardi, Giulia Hyeraci, Morten Andersen, Sarah Brogger Kristiansen, Christine Erikstrup Hallgreen, Olaf Klungel, Miriam Sturkenboom

Summary: The study found that the 2018 risk minimisation measures had limited impact on the utilization patterns of oral retinoids among females of childbearing age in four European countries. Pregnancy still occurred during retinoid use, and pregnant women were still prescribed with these drugs. Regulators, policymakers, prescribers, and researchers need to reconsider implementation strategies to prevent any temporary association between pregnancy and retinoid use.

FRONTIERS IN PHARMACOLOGY (2023)

Article Endocrinology & Metabolism

Bone Microarchitecture and Strength Changes During Teriparatide and Zoledronic Acid Treatment in a Patient with Pregnancy and Lactation-Associated Osteoporosis with Multiple Vertebral Fractures

Sanne Treurniet, Melissa S. A. M. Bevers, Caroline E. E. Wyers, Dimitra Micha, Bernd P. P. Teunissen, Mariet W. W. Elting, Joop P. P. van den Bergh, Elisabeth M. W. Eekhoff

Summary: In this report, a 34-year-old woman with severe osteoporosis and multiple vertebral fractures after her first pregnancy was treated with teriparatide and zoledronic acid. Significant improvements in bone mineral density, microarchitecture, and strength were observed at the hip, spine, and distal radius, but remained severely impaired compared to healthy controls at 40 months postpartum.

CALCIFIED TISSUE INTERNATIONAL (2023)

Article Rheumatology

Longitudinal associations between body mass index and changes in disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab

Theresa Burkard, Enriqueta Vallejo-Yague, Kim Lauper, Axel Finckh, Thomas Hugle, Andrea M. Burden

Summary: The study found that an increase in BMI may not result in changes in DAS28-esr in patients receiving infliximab, but may lead to a decrease in joint erosions.

RMD OPEN (2023)

No Data Available